Spectral Medical Inc EDT-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 07/30/21 EDT
0.38UNCH (UNCH)
Volume
109,818
52 week range
0.34 - 0.76

...

Loading . . .
  • Open0.385
  • Day High0.385
  • Day Low0.365
  • Prev Close0.38
  • 52 Week High0.76
  • 52 Week High Date02/18/21
  • 52 Week Low0.34
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap73.36M
  • Shares Out239.95M
  • 10 Day Average Volume358,056.36
  • Dividend-
  • Dividend Yield-
  • Beta1.55
  • YTD % Change-6.17

KEY STATS

  • Open0.385
  • Day High0.385
  • Day Low0.365
  • Prev Close0.38
  • 52 Week High0.76
  • 52 Week High Date02/18/21
  • 52 Week Low0.34
  • 52 Week Low Date11/02/20
  • Market Cap73.36M
  • Shares Out239.95M
  • 10 Day Average Volume358,056.36
  • Dividend-
  • Dividend Yield-
  • Beta1.55
  • YTD % Change-6.17

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-12.19
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Spectral Medical Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Spectral Medical Inc. is a late stage theranostic company advancing therapeutic options for sepsis and septic shock. The Company has developed a product for the treatment of patients with septic shock, Toraymyxin (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s Endotoxin Activity Assay (EAA). The EAA is a rapid in-vitro diagnostic test that measures negative bacterial cell wall...
Anthony Bihl III
Chairman
Chris Seto
Chief Executive Officer
Paul Walker M.D., Ph.D.
President
Debra Foster
Vice President
Gualitiero Guadagni
Vice President
Address
135 - 2 The West Mall
Toronto, ON
M9C 1C2
Canada